Article Text

Download PDFPDF
Low-Dose Intravenous Lidocaine as Treatment for Proctalgia Fugax
  1. Roni Peleg, M.D. and
  2. Pesach Shvartzman, M.D.
  1. From the Department of Family Medicine, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel.
  1. Reprint requests: Roni Peleg, M.D., Department of Family Medicine, Ben Gurion University of the Negev, PO Box 653, Beer-Sheva, 84105, Israel. E-mail:


Background Proctalgia fugax is characterized by a sudden internal anal sphincter and anorectic ring attack of pain of a short duration.

Objective Description of the influence of intravenous lidocaine treatment for proctalgia fugax.

Case Report A 28-year-old patient suffering of proctalgia fugax for 8 months. Conventional treatment efforts did not improve his condition. A single dose of an intravenous lidocaine infusion completely stopped his pain attacks.

Conclusions Based on the experience reported in this case and the potential benefit of this treatment for proctalgia fugax, controlled studies comparing intravenous lidocaine with placebo should be conducted to confirm the observation and to provide a more concrete basis for the use of intravenous lidocaine for this indication.

  • Proctalgia fugax
  • Intravenous lidocaine

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.